Responses
ORIGINAL ARTICLES
Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.